These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10633069)

  • 1. Is formation of visible channels in a phospholipid bilayer by botulinum neurotoxin type B sensitive to its disulfide?
    Flicker PF; Robinson JP; DasGupta BR
    J Struct Biol; 1999 Dec; 128(3):297-304. PubMed ID: 10633069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles.
    Schmid MF; Robinson JP; DasGupta BR
    Nature; 1993 Aug; 364(6440):827-30. PubMed ID: 7689178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent structure of botulinum neurotoxin type B; location of sulfhydryl groups and disulfide bridge and identification of C-termini of light and heavy chains.
    Antharavally BS; DasGupta BR
    J Protein Chem; 1998 Jul; 17(5):417-28. PubMed ID: 9717738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease activity of botulinum neurotoxin type E and its light chain: cleavage of actin.
    DasGupta BR; Tepp W
    Biochem Biophys Res Commun; 1993 Jan; 190(2):470-4. PubMed ID: 8427588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons.
    Pirazzini M; Rossetto O; Bolognese P; Shone CC; Montecucco C
    Cell Microbiol; 2011 Nov; 13(11):1731-43. PubMed ID: 21790947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bond reduction corresponds to dimerization and hydrophobi-city changes of Clostridium botulinum type A neurotoxin.
    Wey JJ; Tang SS; Wu TY
    Acta Pharmacol Sin; 2006 Sep; 27(9):1238-46. PubMed ID: 16923346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B.
    Eswaramoorthy S; Kumaran D; Swaminathan S
    Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1743-6. PubMed ID: 11679763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The light chain of botulinum neurotoxin forms channels in a lipid membrane.
    Kamata Y; Kozaki S
    Biochem Biophys Res Commun; 1994 Nov; 205(1):751-7. PubMed ID: 7999108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
    Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
    Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of the botulinum neurotoxin molecule that govern binding and transcytosis across polarized human intestinal epithelial cells.
    Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 2004 Aug; 310(2):633-41. PubMed ID: 15140915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endopeptidase activities of botulinum neurotoxin type B complex, holotoxin, and light chain.
    Wang HH; Riding S; Lindo P; Singh BR
    Appl Environ Microbiol; 2010 Oct; 76(19):6658-63. PubMed ID: 20693440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells.
    Giménez J; Lomneth R; DasGupta BR
    Toxicon; 1994 Sep; 32(9):1137-46. PubMed ID: 7801349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
    Kukreja RV; Sharma SK; Singh BR
    Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.
    Chellappan G; Kumar R; Santos E; Goyal D; Cai S; Singh BR
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1510-6. PubMed ID: 26012869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron density projection map of the botulinum neurotoxin 900-kilodalton complex by electron crystallography.
    Burkard F; Chen F; Kuziemko GM; Stevens RC
    J Struct Biol; 1997 Oct; 120(1):78-84. PubMed ID: 9356295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Channels formed in phospholipid bilayer membranes by diphtheria, tetanus, botulinum and anthrax toxin.
    Finkelstein A
    J Physiol (Paris); 1990; 84(2):188-90. PubMed ID: 1705290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Nov; 18(8):885-92. PubMed ID: 10839626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin type A: limited proteolysis by endoproteinase Glu-C and alpha-chymotrypsin enhanced following reduction; identification of the cleaved sites and fragments.
    Beecher DJ; DasGupta BR
    J Protein Chem; 1997 Oct; 16(7):701-12. PubMed ID: 9330228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.